E Fund Management Co., Ltd. Myriad Genetics Inc Transaction History

E Fund Management Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.59 - $23.59 $207,139 - $277,795	11,776 New	11,776 $251,000
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $2,542 - $3,691	159 Added 1.51%	10,709 $172,000
Q2 2023 Aug 11, 2023	BUY	$17.56 - $23.76 $15,997 - $21,645	911 Added 9.45%	10,550 $245,000
Q1 2023 May 11, 2023	SELL	$15.26 - $23.75 $18,052 - $28,096	-1,183 Reduced 10.93%	9,639 $224,000
Q4 2022 Feb 14, 2023	SELL	$14.51 - $20.99 $13,944 - $20,171	-961 Reduced 8.16%	10,822 $157,000
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $12,710 - $19,460	-698 Reduced 5.59%	11,783 $225,000
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $131,830 - $207,402	8,014 Added 179.4%	12,481 $227,000
Q1 2021 May 12, 2021	BUY	$19.92 - $31.6 $88,982 - $141,157	4,467 New	4,467 $136,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.